Muhiddin Dervis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Muhiddin Dervis has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Ruaa Mustafa Qafesha
Faculty of Medicine Al‐Quds University Jerusalem Palestine
4 shared publications - Ahmed Afify
Faculty of Medicine, Benha University, Benha 13518, Egypt
2 shared publications - Doaa Mashaly
Faculty of Medicine, October 6 University, Giza 12585, Egypt
2 shared publications - Israa Sharabati
Faculty of Medicine, Al-Quds University, Jerusalem, Palestine
2 shared publications - Mohamad Rustm
Faculty of Medicine, Ankara Yildrim Beyazit University, Ankara 06800, Turkey
2 shared publications - Muataz Kashbour
Diagnostic Radiology Department, National Cancer Institute, Misrata, Libya
2 shared publications
Latest Publications
- Open Access
- 29 May 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (6) , 635
Magnetic Particle Imaging for Pulmonary Applications: Technological Advances, Biological Insights, and Clinical Translation
Background: Magnetic particle imaging (MPI) is an emerging, tracer-based modality that directly detects superparamagnetic iron oxide nanoparticles (SPIONs) with exceptional sensitivity, quantitative signal behavior, and full immunity to air–tissue susceptibility artifacts. These features make MPI particularly well-suited for pulmonary imaging, where traditional techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine-based ventilation/perfusion (V/Q) imaging are limited by radiation exposure, low contrast, and motion-related signal degradation. Objective: This review synthesizes the current state of MPI for lung imaging, with emphasis on its physical principles, tracer development, preclinical applications, and its potential role in assessing pulmonary perfusion, vascular integrity, inflammation, and therapeutic responses. Methods: A systematic evaluation of preclinical studies was performed across three major application domains: pulmonary perfusion mapping, cell tracking and therapeutic monitoring, and vascular injury and permeability assessment. Study designs, SPION formulations, MPI acquisition strategies, and validation methods, including histopathology, biodistribution, broncho-alveolar lavage fluid (BALF) analysis, and Evans Blue assays, were examined to characterize methodological consistency and imaging performance. Results: MPI consistently demonstrated high-contrast, quantitative visualization of pulmonary blood flow, endothelial barrier disruption, inflammatory signaling, and transplanted or inhaled cell populations. Tracer engineering played a critical role: macroaggregated albumin superparamagnetic iron oxide nanoparticles (MAA-SPIONs) enabled capillary-level perfusion mapping, LS-008 improved temporal resolution and vascular delineation, Synomag/Synomag-D allowed quantification of vascular leakage in acute and chronic lung injury, and vascular cell adhesion molecule-1 (VCAM-1)-targeted probes provided molecular-level assessment of inflammation. Hybrid MPI-CT and MPI-MRI approaches further enhanced anatomic localization and enabled accurate pulmonary blood volume (PBV) estimation. Across studies, MPI measurements showed strong agreement with established biological assays and remained free of the artifacts that limit CT and MRI in the lung. Conclusions: Preclinical evidence demonstrates that MPI is a robust, radiation-free, and quantitatively precise modality for functional and molecular lung imaging. Its ability to map perfusion, track therapeutic agents, and noninvasively quantify vascular permeability positions MPI as a promising future alternative or complement to CT, MRI, and nuclear medicine for pulmonary assessment. Continued tracer optimization, system scaling, and clinical validation are key steps toward translating MPI into routine clinical use.
- 29 May 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (6) , 635
Open AccessMagnetic Particle Imaging for Pulmonary Applications: Technological Advances, Biological Insights, and Clinical Translation
Background: Magnetic particle imaging (MPI) is an emerging, tracer-based modality that directly detects superparamagnetic iron oxide nanoparticles (SPIONs) with exceptional sensitivity, quantitative signal behavior, and full immunity to air–tissue susceptibility artifacts. These features make MPI particularly well-suited for pulmonary imaging, where traditional techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine-based ventilation/perfusion (V/Q) imaging are limited by radiation exposure, low contrast, and motion-related signal degradation. Objective: This review synthesizes the current state of MPI for lung imaging, with emphasis on its physical principles, tracer development, preclinical applications, and its potential role in assessing pulmonary perfusion, vascular integrity, inflammation, and therapeutic responses. Methods: A systematic evaluation of preclinical studies was performed across three major application domains: pulmonary perfusion mapping, cell tracking and therapeutic monitoring, and vascular injury and permeability assessment. Study designs, SPION formulations, MPI acquisition strategies, and validation methods, including histopathology, biodistribution, broncho-alveolar lavage fluid (BALF) analysis, and Evans Blue assays, were examined to characterize methodological consistency and imaging performance. Results: MPI consistently demonstrated high-contrast, quantitative visualization of pulmonary blood flow, endothelial barrier disruption, inflammatory signaling, and transplanted or inhaled cell populations. Tracer engineering played a critical role: macroaggregated albumin superparamagnetic iron oxide nanoparticles (MAA-SPIONs) enabled capillary-level perfusion mapping, LS-008 improved temporal resolution and vascular delineation, Synomag/Synomag-D allowed quantification of vascular leakage in acute and chronic lung injury, and vascular cell adhesion molecule-1 (VCAM-1)-targeted probes provided molecular-level assessment of inflammation. Hybrid MPI-CT and MPI-MRI approaches further enhanced anatomic localization and enabled accurate pulmonary blood volume (PBV) estimation. Across studies, MPI measurements showed strong agreement with established biological assays and remained free of the artifacts that limit CT and MRI in the lung. Conclusions: Preclinical evidence demonstrates that MPI is a robust, radiation-free, and quantitatively precise modality for functional and molecular lung imaging. Its ability to map perfusion, track therapeutic agents, and noninvasively quantify vascular permeability positions MPI as a promising future alternative or complement to CT, MRI, and nuclear medicine for pulmonary assessment. Continued tracer optimization, system scaling, and clinical validation are key steps toward translating MPI into routine clinical use.
- 24 December 2025
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 99 (1177) , 37-49
Diagnostic performance of artificial intelligence in radiographs for pneumoperitoneum detection: a systematic review and meta-analysis
Objectives: The aim of this systematic review and meta-analysis is to evaluate the diagnostic accuracy of artificial intelligence (AI) based algorithms in detecting pneumoperitoneum on medical imaging. Methods: Online databases were searched until June 2024. Statistical analyses were conducted using Open Meta-Analyst software and STATA 17.0. The analysis included overall sensitivity, specificity, diagnostic odds ratio (DOR), and area under the curve (AUC). Meta-regression and subgroup analyses were conducted to identify sources of heterogeneity among the included studies. Results: Among the 14 AI-based radiograph models analysed, AI demonstrated high diagnostic accuracy for pneumoperitoneum, with a sensitivity of 83.6% (95% CI: 80.2%-86.4%), specificity of 92.9% (95% CI: 88.3%-95.8%), negative likelihood ratio of 0.18, and positive likelihood ratio of 11.76 (all P < .001). Deep learning models showed higher sensitivity (83.7%) but slightly lower specificity (91.2%) compared to machine learning models (sensitivity 77%, specificity 98%). The AUC was 0.93, with a DOR of 76. Meta-regression revealed larger sample sizes significantly improved specificity. Deeks’ funnel plot showed no publication bias. Conclusions: AI models are effective in diagnosing pneumoperitoneum. The high accuracy of these models enhances the potential for rapid and precise detection, thereby improving patient management. Future prospective multicentre studies with larger sample sizes and comparisons of various models are highly anticipated. Advances in knowledge: This is the first meta-analysis to evaluate AI’s diagnostic accuracy for pneumoperitoneum, revealing high sensitivity and specificity, comparing deep learning and machine learning performance, and highlighting AI’s potential to enhance early diagnosis and prioritization in clinical workflows.
- 24 December 2025
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 99 (1177) , 37-49
Diagnostic performance of artificial intelligence in radiographs for pneumoperitoneum detection: a systematic review and meta-analysis
Objectives: The aim of this systematic review and meta-analysis is to evaluate the diagnostic accuracy of artificial intelligence (AI) based algorithms in detecting pneumoperitoneum on medical imaging. Methods: Online databases were searched until June 2024. Statistical analyses were conducted using Open Meta-Analyst software and STATA 17.0. The analysis included overall sensitivity, specificity, diagnostic odds ratio (DOR), and area under the curve (AUC). Meta-regression and subgroup analyses were conducted to identify sources of heterogeneity among the included studies. Results: Among the 14 AI-based radiograph models analysed, AI demonstrated high diagnostic accuracy for pneumoperitoneum, with a sensitivity of 83.6% (95% CI: 80.2%-86.4%), specificity of 92.9% (95% CI: 88.3%-95.8%), negative likelihood ratio of 0.18, and positive likelihood ratio of 11.76 (all P < .001). Deep learning models showed higher sensitivity (83.7%) but slightly lower specificity (91.2%) compared to machine learning models (sensitivity 77%, specificity 98%). The AUC was 0.93, with a DOR of 76. Meta-regression revealed larger sample sizes significantly improved specificity. Deeks’ funnel plot showed no publication bias. Conclusions: AI models are effective in diagnosing pneumoperitoneum. The high accuracy of these models enhances the potential for rapid and precise detection, thereby improving patient management. Future prospective multicentre studies with larger sample sizes and comparisons of various models are highly anticipated. Advances in knowledge: This is the first meta-analysis to evaluate AI’s diagnostic accuracy for pneumoperitoneum, revealing high sensitivity and specificity, comparing deep learning and machine learning performance, and highlighting AI’s potential to enhance early diagnosis and prioritization in clinical workflows.
- 11 December 2025
- Published by Elsevier in Radiography
- Vol. 32 (4) , 103280
Laser positioning versus conventional CT-Guided lung biopsy: A systematic review and meta-analysis of clinical outcomes
- 11 December 2025
- Published by Elsevier in Radiography
- Vol. 32 (4) , 103280
Laser positioning versus conventional CT-Guided lung biopsy: A systematic review and meta-analysis of clinical outcomes
- Open Access
- 11 November 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (11) , 1235
Cardiovascular Imaging Applications, Implementations, and Challenges Using Novel Magnetic Particle Imaging
Magnetic Particle Imaging (MPI) is a new type of tracer-based imaging that has great spatial and temporal resolution, does not require ionizing radiation, and can see deep into tissues by directly measuring the nonlinear magnetization response of superparamagnetic iron oxide nanoparticles (SPIONs). Unlike Magnetic Resonance Imaging (MRI) or Computed Tomography (CT), MPI has very high contrast and quantitative accuracy, which makes it perfect for use in dynamic cardiovascular applications. This study presents a full picture of the most recent changes in cardiac MPI, such as the physics behind Field-Free Point (FFP) and Field-Free Line (FFL) encoding, new ideas for tracer design, and important steps in the evolution of scanner hardware. We discuss the clinical relevance of cardiac MPI in visualizing myocardial perfusion, quantifying blood flow, and guiding real-time interventions. A hybrid imaging workflow, which improves anatomical detail and functional assessment, is utilized to explore the integration of MPI with complementary modalities, particularly MRI. By consolidating recent preclinical breakthroughs and highlighting the roadmap toward human-scale implementation, this article underscores the transformative potential of MPI in cardiac diagnostics and image-guided therapy.
- 11 November 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (11) , 1235
Open AccessCardiovascular Imaging Applications, Implementations, and Challenges Using Novel Magnetic Particle Imaging
Magnetic Particle Imaging (MPI) is a new type of tracer-based imaging that has great spatial and temporal resolution, does not require ionizing radiation, and can see deep into tissues by directly measuring the nonlinear magnetization response of superparamagnetic iron oxide nanoparticles (SPIONs). Unlike Magnetic Resonance Imaging (MRI) or Computed Tomography (CT), MPI has very high contrast and quantitative accuracy, which makes it perfect for use in dynamic cardiovascular applications. This study presents a full picture of the most recent changes in cardiac MPI, such as the physics behind Field-Free Point (FFP) and Field-Free Line (FFL) encoding, new ideas for tracer design, and important steps in the evolution of scanner hardware. We discuss the clinical relevance of cardiac MPI in visualizing myocardial perfusion, quantifying blood flow, and guiding real-time interventions. A hybrid imaging workflow, which improves anatomical detail and functional assessment, is utilized to explore the integration of MPI with complementary modalities, particularly MRI. By consolidating recent preclinical breakthroughs and highlighting the roadmap toward human-scale implementation, this article underscores the transformative potential of MPI in cardiac diagnostics and image-guided therapy.
- Open Access
- 18 June 2025
- Published by IntechOpen
Heat over Surgery: The Rise of Thermal Ablation in Thyroid Nodules Treatment
Thyroid nodules (TNs) are a common endocrine condition, typically benign, though some may cause symptoms that require clinical management. While thyroidectomy has traditionally been the standard treatment, its invasive nature and associated risks—such as vocal changes, hypocalcemia, and visible scarring—have led to increasing interest in less invasive approaches. In this context, ultrasound-guided thermal ablation (UG-TA) has emerged as a promising, minimally invasive alternative for treating benign and selected malignant thyroid nodules (TNs). This chapter provides an overview of four key thermal ablation (TA) techniques: radiofrequency ablation (RFA), microwave ablation (MWA), laser ablation (LA), and high-intensity focused ultrasound (HIFU). It explores their underlying mechanisms, clinical indications, and comparative effectiveness. Evidence from recent meta-analyses and long-term studies suggests that these techniques can achieve significant volume reduction with fewer complications and faster recovery times compared to surgery. Although thyroidectomy may still offer the most substantial volume reduction in some instances, UG-TA procedures present notable advantages, including improved safety profiles, shorter hospital stays, and more favorable cosmetic outcomes. Although TA has demonstrated promising results, concerns persist regarding procedural standardization, operator dependency, and long-term oncologic outcomes. This chapter reviews current evidence, compares various thermal ablation modalities with each other and with surgery, and highlights key directions for future research and clinical practice.
- 18 June 2025
- Published by IntechOpen
Open AccessHeat over Surgery: The Rise of Thermal Ablation in Thyroid Nodules Treatment
Thyroid nodules (TNs) are a common endocrine condition, typically benign, though some may cause symptoms that require clinical management. While thyroidectomy has traditionally been the standard treatment, its invasive nature and associated risks—such as vocal changes, hypocalcemia, and visible scarring—have led to increasing interest in less invasive approaches. In this context, ultrasound-guided thermal ablation (UG-TA) has emerged as a promising, minimally invasive alternative for treating benign and selected malignant thyroid nodules (TNs). This chapter provides an overview of four key thermal ablation (TA) techniques: radiofrequency ablation (RFA), microwave ablation (MWA), laser ablation (LA), and high-intensity focused ultrasound (HIFU). It explores their underlying mechanisms, clinical indications, and comparative effectiveness. Evidence from recent meta-analyses and long-term studies suggests that these techniques can achieve significant volume reduction with fewer complications and faster recovery times compared to surgery. Although thyroidectomy may still offer the most substantial volume reduction in some instances, UG-TA procedures present notable advantages, including improved safety profiles, shorter hospital stays, and more favorable cosmetic outcomes. Although TA has demonstrated promising results, concerns persist regarding procedural standardization, operator dependency, and long-term oncologic outcomes. This chapter reviews current evidence, compares various thermal ablation modalities with each other and with surgery, and highlights key directions for future research and clinical practice.
- Open Access
- 14 May 2025
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 69 (6) , 547-560
L-carnitine supplementation to prevent postoperative complications after cardiac surgery: A systematic review and meta-analysis of randomised clinical trials
Background and Aims: Cardiac surgeries often lead to postoperative complications, which affect recovery and increase morbidity and mortality. This systematic review aims to assess L-carnitine’s effect on preventing postoperative complications across various cardiac surgeries, addressing gaps in current literature on its potential therapeutic benefits. Methods: We systematically searched Web of Science, Cochrane, Embase, PubMed, and Scopus databases until March 2025. Statistical analysis was performed using R version 4.3.2. Effect sizes were measured with relative risks (RR) for dichotomous outcomes and mean differences (MD) for continuous outcomes, while heterogeneity was evaluated using the I² statistic. Results: Thirteen randomised controlled trials(RCTs) with 786 patients were included. L-carnitine significantly increased the cardiac index (CI) (MD: 0.14; 95% CI: 0.07, 0.20; P < 0.01) and left ventricular stroke work index (LVSWI) (MD: 0.42; 95% CI: 0.06, 0.78; P = 0.02). In addition, L-carnitine significantly improved the left ventricular ejection fraction (LVEF) (MD: 7.88; 95% CI: 6.67, 9.09; P < 0.01), with a significant reduction in postoperative atrial fibrillation (POAF) (RR: 0.53; 95% CI: 0.30, 0.95; P = 0.03). In contrast, there was no significant reduction in in-hospital mortality (RR: 0.51; 95% CI: 0.10, 2.63; P = 1.00) and stroke incidence (RR: 0.85; 95% CI: 0.12, 5.76; P = 0.82). Conclusion: Preoperative administration of L-carnitine demonstrates meaningful short-term benefits in enhancing CI, LVSWI, and LVEF while reducing the incidence of POAF following cardiac surgery. These findings suggest a potential role for L-carnitine supplementation in optimising perioperative cardiac care, enhancing recovery, and reducing complications following cardiac surgery. However, the existing studies are limited in scope, making it challenging to draw robust conclusions.
- 14 May 2025
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 69 (6) , 547-560
Open AccessL-carnitine supplementation to prevent postoperative complications after cardiac surgery: A systematic review and meta-analysis of randomised clinical trials
Background and Aims: Cardiac surgeries often lead to postoperative complications, which affect recovery and increase morbidity and mortality. This systematic review aims to assess L-carnitine’s effect on preventing postoperative complications across various cardiac surgeries, addressing gaps in current literature on its potential therapeutic benefits. Methods: We systematically searched Web of Science, Cochrane, Embase, PubMed, and Scopus databases until March 2025. Statistical analysis was performed using R version 4.3.2. Effect sizes were measured with relative risks (RR) for dichotomous outcomes and mean differences (MD) for continuous outcomes, while heterogeneity was evaluated using the I² statistic. Results: Thirteen randomised controlled trials(RCTs) with 786 patients were included. L-carnitine significantly increased the cardiac index (CI) (MD: 0.14; 95% CI: 0.07, 0.20; P < 0.01) and left ventricular stroke work index (LVSWI) (MD: 0.42; 95% CI: 0.06, 0.78; P = 0.02). In addition, L-carnitine significantly improved the left ventricular ejection fraction (LVEF) (MD: 7.88; 95% CI: 6.67, 9.09; P < 0.01), with a significant reduction in postoperative atrial fibrillation (POAF) (RR: 0.53; 95% CI: 0.30, 0.95; P = 0.03). In contrast, there was no significant reduction in in-hospital mortality (RR: 0.51; 95% CI: 0.10, 2.63; P = 1.00) and stroke incidence (RR: 0.85; 95% CI: 0.12, 5.76; P = 0.82). Conclusion: Preoperative administration of L-carnitine demonstrates meaningful short-term benefits in enhancing CI, LVSWI, and LVEF while reducing the incidence of POAF following cardiac surgery. These findings suggest a potential role for L-carnitine supplementation in optimising perioperative cardiac care, enhancing recovery, and reducing complications following cardiac surgery. However, the existing studies are limited in scope, making it challenging to draw robust conclusions.
- Open Access
- 28 January 2025
- Published by Elsevier in Radiology Case Reports
- Vol. 20 (4) , 2043-2047
Acute soft head syndrome in sickle cell disease: A rare and under-recognized complication with diagnostic challenges
- 28 January 2025
- Published by Elsevier in Radiology Case Reports
- Vol. 20 (4) , 2043-2047
Open AccessAcute soft head syndrome in sickle cell disease: A rare and under-recognized complication with diagnostic challenges